These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36519327)

  • 21. In Vitro Comparison of Recombinant and Plasma-Derived von Willebrand Factor Concentrate for Treatment of Acquired von Willebrand Syndrome in Adult Extracorporeal Membrane Oxygenation Patients.
    Mazzeffi M; Henderson R; Krause E; Rabin J; Madathil R; Chow J; Grazioli A; Meyer M; Wu Z; Tanaka K
    Anesth Analg; 2022 Feb; 134(2):312-321. PubMed ID: 34903705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by heparin of thrombin-catalyzed activation of the factor VIII-von Willebrand factor complex.
    Barrow RT; Healey JF; Lollar P
    J Biol Chem; 1994 Jan; 269(1):593-8. PubMed ID: 8276857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles.
    Andersson LO; Brown JE
    Biochem J; 1981 Oct; 200(1):161-7. PubMed ID: 6800356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD).
    Mohammed S; Favaloro EJ
    Methods Mol Biol; 2017; 1646():461-472. PubMed ID: 28804848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor.
    Béguin S; Kumar R; Keularts I; Seligsohn U; Coller BS; Hemker HC
    Blood; 1999 Jan; 93(2):564-70. PubMed ID: 9885217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory diagnosis of von Willebrand disease.
    Roberts JC; Flood VH
    Int J Lab Hematol; 2015 May; 37 Suppl 1(Suppl 1):11-7. PubMed ID: 25976955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A.
    Stokol T; Trepanier L; Parry BW; Finnin BC
    Res Vet Sci; 1997; 63(1):23-7. PubMed ID: 9368952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.
    Koppelman SJ; Hackeng TM; Sixma JJ; Bouma BN
    Blood; 1995 Aug; 86(3):1062-71. PubMed ID: 7620160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelets compensate for poor thrombin generation in type 3 von Willebrand disease.
    Szanto T; Nummi V; Jouppila A; Brinkman HJM; Lassila R
    Platelets; 2020; 31(1):103-111. PubMed ID: 30836803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to keep the factor VIII/von Willebrand factor complex in the circulation.
    Denis CV; Lenting PJ
    Haematologica; 2022 Sep; 107(9):2011-2013. PubMed ID: 34818875
    [No Abstract]   [Full Text] [Related]  

  • 33. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
    Karlman M; Holmström M; Wiman B
    Thromb Res; 2011 Jan; 127(1):47-50. PubMed ID: 21094987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of human factor VIII and interaction with von Willebrand factor. An electron microscopic study.
    Heijnen HF; Koedam JA; Sandberg H; Beeser-Visser NH; Slot JW; Sixma JJ
    Eur J Biochem; 1990 Dec; 194(2):491-8. PubMed ID: 2125268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand factor: another janus-faced hemostasis protein.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2008 Oct; 34(7):663-9. PubMed ID: 19085767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Von Willebrand factor, factor VIII and the factor VIII/von Willebrand factor complex.
    Ingerslev J
    Dan Med Bull; 1990 Oct; 37(5):385-406. PubMed ID: 2125548
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor.
    Casonato A; Pontara E; Sartorello F; Gemmati D; Cattini MG; Girolami A
    Haematologica; 2001 Oct; 86(10):1110-1. PubMed ID: 11602423
    [No Abstract]   [Full Text] [Related]  

  • 39. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.
    Chang P; Aronson DL; Borenstein DG; Kessler CM
    Am J Hematol; 1995 Oct; 50(2):79-83. PubMed ID: 7573004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents.
    Caron C; Mazurier C; Goudemand J
    Br J Haematol; 2002 Jun; 117(3):716-8. PubMed ID: 12028048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.